Combining real-world data with multi-omics data, Jing and coworkers developed a bivariate regression model for LCP1 and ADPGK, and validated it in a cohort of cancer patients receiving anti–PD-1/PD-L1 inhibitors, revealing the highest correlation between these two values and the presence of irAEs. Here, PDCD1 is linked to cancer.